<p class="title">Shares of biotechnology firm Biocon on Monday surged over 7% after the company said it has received an EIR from the USFDA on closure of inspection of its aseptic drug product facility.</p>.<p class="bodytext">The stock soared 7.27% to settle at Rs 423 on BSE. During the day, it zoomed 7.74% to Rs 424.90 - its 52-week high. At NSE, shares of the company gained 7.31% to end at Rs 423.20.</p>.<p class="bodytext">In terms of equity volume, 7.55 lakh shares of the company were traded on BSE and over 80 lakh shares changed hands at NSE during the day.</p>.<p class="bodytext">Biocon on Monday said it has received the EIR (Establishment Inspection Report) with 'voluntary action indicated' status from the USFDA on closure of inspection of its aseptic drug product facility.</p>
<p class="title">Shares of biotechnology firm Biocon on Monday surged over 7% after the company said it has received an EIR from the USFDA on closure of inspection of its aseptic drug product facility.</p>.<p class="bodytext">The stock soared 7.27% to settle at Rs 423 on BSE. During the day, it zoomed 7.74% to Rs 424.90 - its 52-week high. At NSE, shares of the company gained 7.31% to end at Rs 423.20.</p>.<p class="bodytext">In terms of equity volume, 7.55 lakh shares of the company were traded on BSE and over 80 lakh shares changed hands at NSE during the day.</p>.<p class="bodytext">Biocon on Monday said it has received the EIR (Establishment Inspection Report) with 'voluntary action indicated' status from the USFDA on closure of inspection of its aseptic drug product facility.</p>